Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems

被引：11
|
作者：
Akturk, Halis K. [1 ]
Battelino, Tadej [2 ,3 ]
Castaneda, Javier [4 ]
Arrieta, Arcelia [4 ]
van den Heuvel, Tim [4 ]
Cohen, Ohad [4 ]
机构：
[1] Univ Colorado, Barbara Davis Ctr Diabet, Aurora, CO USA
[2] Univ Ljubljana, Univ Med Ctr Ljubljana, Ljubljana, Slovenia
[3] Univ Ljubljana, Fac Med, Ljubljana, Slovenia
[4] Medtron Int Trading Sarl, Route Molliau 31, CH-1131 Tolochenaz, Switzerland
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2024年 / 26卷
关键词：
Automated insulin delivery; Time in tight range; Insulin therapy; Closed-loop; Insulin pump; MiniMed (TM); Glucose control; INTERNATIONAL CONSENSUS; DIABETIC-RETINOPATHY; METRICS; COMPLICATIONS; ASSOCIATION; INITIATION;
D O I：
10.1089/dia.2023.0432
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The concept of maintaining blood glucose levels within the 70-180 mg/dL range, known as time-in-range, has raised questions regarding its representation of true physiological euglycemia. Some have speculated that focusing on the time spent within the 70-140 mg/dL range, introduced as time in tight range (TITR) through the International Consensus statement, could serve as a more precise metric for assessing normoglycemia in individuals with type 1 diabetes. This article delves into the current status of TITR as an emerging marker and explores how advanced hybrid closed-loop systems may offer a promising avenue for achieving this higher level of glycemic control.
引用
收藏
页码：102 / 106
页数：5
相关论文
共 50 条
  • [11] Real world experience using advanced closed-loop hybrid systems vs other automated insulin delivery systems for pregnant women with type 1 diabetes
    Gomez, A.
    Henao, D.
    Parra, D.
    Grassi, B.
    Serrano, M. N.
    Rondon, M.
    DIABETOLOGIA, 2024, 67 : S367 - S367
  • [12] RAPID IMPROVEMENT IN TIME IN RANGE AFTER ADVANCED HYBRID CLOSED-LOOP SYSTEM INITIATION
    Beato-Vibora, P. I.
    Gallego-Gamero, F.
    Ambrojo-Lopez, A.
    Gil-Poch, E.
    Martin-Romo, I.
    Carrasco-Munoz, M.
    Arroyo-Diez, F.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A79 - A79
  • [13] Effect of Adjuvant Injected Pramlintide on Closed-Loop Automated Insulin Delivery
    Weinzimer, Stuart A.
    Sherr, Jennifer L.
    Cengiz, Eda
    Kim, Grace
    Carria, Lori
    Tamborlane, William V.
    DIABETES, 2011, 60 : A253 - A253
  • [14] IMPLEMENTATION OF FULLY AUTOMATED CLOSED-LOOP INSULIN DELIVERY FOR INPATIENTS WITH DIABETES
    Hobday, N.
    Hartnell, S.
    Lake, A.
    Davenport, K.
    Hovorka, R.
    Bansiya, V.
    Boughton, C.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A24 - A24
  • [15] AI UPGRADES AUTOMATED INSULIN DELIVERY TOWARDS A FULLY CLOSED-LOOP
    Herrero, P.
    Armiger, R.
    Daniels, J.
    Reddy, M.
    Oliver, N.
    Georgiou, P.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A4 - A4
  • [16] Recent Advances in Closed-Loop and Smart Insulin Delivery Systems
    Li, Zhenyi
    Hu, Xiaoyu
    Jiang, Juli
    Zhang, Dongmei
    Xiao, Shoujun
    Lin, Chen
    Wang, Leyong
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2018, 38 (01) : 29 - 39
  • [17] Intelligent Closed-Loop Insulin Delivery Systems for ICU Patients
    Wang, Youqing
    Xie, Hongzhi
    Jiang, Xu
    Liu, Bo
    IEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICS, 2014, 18 (01) : 290 - 299
  • [18] TIME-DELAY COMPENSATION FOR CLOSED-LOOP INSULIN DELIVERY SYSTEMS - A SIMULATION STUDY
    REBOLDI, GP
    HOME, PD
    CALABRESE, G
    FABIETTI, PG
    BRUNETTI, P
    BENEDETTI, MM
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1991, 14 (06): : 350 - 358
  • [19] Insulin Patch Pumps: Their Development and Future in Closed-Loop Systems
    Anhalt, Henry
    Bohannon, Nancy J. V.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2010, 12 : S51 - S58
  • [20] Practical implementation of automated closed-loop insulin delivery: A French position statement
    Tubiana-Rufi, N.
    Schaepelynck, P.
    Franc, S.
    Chaillous, L.
    Joubert, M.
    Renard, E.
    Reznik, Y.
    Abettan, C.
    Bismuth, E.
    Beltrand, J.
    Bonnemaison, E.
    Borot, S.
    Charpentier, G.
    Delemer, B.
    Desserprix, A.
    Durain, D.
    Farret, A.
    Filhol, N.
    Guerci, B.
    Guilhem, I
    Guillot, C.
    Jeandidier, N.
    Lablanche, S.
    Leroy, R.
    Melki, V
    Munch, M.
    Penfornis, A.
    Picard, S.
    Place, J.
    Riveline, J. P.
    Serusclat, P.
    Sola-Gazagnes, A.
    Thivolet, C.
    Hanaire, H.
    Benhamou, P. Y.
    DIABETES & METABOLISM, 2021, 47 (03)
12345